未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 Advanced image-identified extranodal extension of retropharyngeal lymph nodes in the refinement of N classification for nasopharyngeal carcinoma高级图像识别技术在鼻咽癌N分期中精炼咽后淋巴结外侵的进展
Jiang, Wei; Wang, Gao-Yuan; Qin, Guan-Jie; Zhang, Wu-Qi; Zhu, Xiao-Dong; Han, Ya-Qian; Lei, Feng; Shen, Liang-Fang; Yang, Kun-Yu; Cui, Chun-Yan; Tang, Ling-Long; Mao, Yan-Ping; Chen, Lei; Guo, Rui; Li, Ling; Wu, Zheng; Xu, Gui-Qiong; Zhou, Qin; Huang, Jing; Huang, Shao-Hui; Li, Ji-Bin; Liu, Li-Zhi; Ma, Jun 分享 收藏 Perioperative pembrolizumab and lenvatinib for resectable hepatocellular carcinoma: Updated efficacy and safety results from the phase II NeoLEAP-HCC study围术期帕博利珠单抗联合仑伐替尼治疗可切除肝细胞癌：来自II期NeoLEAP-HCC研究的更新疗效和安全性结果Wang, K.; Yang, N.; Xue, H.; Yang, Y-C.; Sun, H.; Zhu, X.; Chen, Y-J.; Kuang, M.; Ye, F.; Shen, S.; Huang, C.; Shen, Y.; Sun, Y-F.; Xue, F.; Liu, J.; Bai, S.; Yang, Z.; Zhou, J.; Fan, J. 分享 收藏 Depth of Radiographic Response as an Independent Prognostic Factor for Patients with Initially Unresectable Hepatocellular Carcinoma Receiving Hepatectomy following Targeted Therapy plus ImmunotherapyXu, Bin; Wang, Lu-Na; Wang, Zi-Yi; He, Tian; Zhu, Xiao-Dong; Shen, Ying-Hao; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan; Huang, Cheng 分享 收藏 CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinomaCRKL通过介导肝细胞癌中肿瘤相关的中性粒细胞浸润来指示anti-PD-1抵抗Xie, Peiyi; Yu, Mincheng; Zhang, Bo; Yu, Qiang; Zhao, Yufei; Wu, Mengyuan; Jin, Lei; Yan, Jiuliang; Zhou, Binghai; Liu, Shuang; Li, Xiaoqiang; Zhou, Chenhao; Zhu, Xiaodong; Huang, Cheng; Xu, Yongfeng; Xiao, Yongsheng; Zhou, Jian; Fan, Jia; Hung, Mien-Chie; Ye, Qinghai; Guo, Lei; Li, Hui 分享 收藏 The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 studyYang, Chao-Xu; Pan, Yang-Xun; Ye, Feng; Zhu, Xiao-Dong; Xue, Jun; Li, Xi; Yuan, Zhen-Gang; Zhang, Lan; Xu, Li; Chen, Yong-Jun; Wang, Nan-Ya; Sun, Hui-Chuan; Liu, Xiu-Feng 分享 收藏 The combination treatment of oncolytic adenovirus H101 with nivolumab for refractory advanced hepatocellular carcinoma: an open-label, single-arm, pilot studyYi, L.; Ning, Z.; Xu, L.; Shen, Y.; Zhu, X.; Yu, W.; Xie, J.; Meng, Z. 分享 收藏 分享 收藏 Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter studyHuang, Cheng; Zhu, Xiao-Dong; Shen, Ying-Hao; Xu, Bin; Wu, Dong; Ji, Yuan; Chen, Ling-Li; Song, Tian-Qiang; Zhang, Wei; Zeng, Zhi-Ming; Huang, Hua-Sheng; Wang, Kui; Huang, Lan-Qing; Chen, Yong-Jun; Yang, Yu-Chen; Zhou, Le-Du; Long, Guo; Zhao, Hai-Tao; Wang, Yun-Chao; Ge, Ning-Ling; Chen, Yi; Tan, Chang-Jun; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan 分享 收藏 Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center studyPan, Yangxun; Zhu, Xiaodong; Liu, Jianwei; Zhong, Jianhong; Zhang, Wei; Shen, Shunli; Jin, Renan; Liu, Hongzhi; Ye, Feng; Hu, Kuan; Xu, Da; Zhang, Yu; Chen, Zhong; Xing, Baocai; Zhou, Ledu; Chen, Yongjun; Zeng, Yongyi; Liang, Xiao; Kuang, Ming; Song, Tianqiang; Xiang, Bangde; Wang, Kui; Sun, Huichuan; Xu, Li 分享 收藏 Criteria for identifying potentially resectable patients with initially oncologically unresectable hepatocellular carcinoma before treatment with lenvatinib plus an anti-PD-1 antibodyXu, Bin; Zhu, Xiao-Dong; Shen, Ying-Hao; Zhu, Jin-Jin; Liu, Jie; Li, Mei-Ling; Tang, Pei-Wen; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan; Huang, Cheng 分享 收藏 Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular CarcinomaZhu, Xiao-Dong; Huang, Cheng; Shen, Ying-Hao; Xu, Bin; Ge, Ning-Ling; Ji, Yuan; Qu, Xu-Dong; Chen, Lingli; Chen, Yi; Li, Mei-Ling; Zhu, Jin-Jin; Tang, Zhao-You; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan 分享 收藏 分享 收藏 Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model体力活动可改善乐伐替尼联合anti-PD-1治疗不可切除肝细胞癌的疗效: 一项回顾性研究和小鼠模型Liu, Xue-Feng; Zhu, Xiao-Dong; Feng, Long-Hai; Li, Xiao-Long; Xu, Bin; Li, Kang-Shuai; Xiao, Nan; Lei, Ming; Sun, Hui-Chuan; Tang, Zhao-You 分享 收藏 Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)肝细胞癌转化治疗中国专家共识 (2021版)Sun, Hui-Chuan; Zhou, Jian; Wang, Zheng; Liu, Xiufeng; Xie, Qing; Jia, Weidong; Zhao, Ming; Bi, Xinyu; Li, Gong; Bai, Xueli; Ji, Yuan; Xu, Li; Zhu, Xiao-Dong; Bai, Dousheng; Chen, Yajin; Chen, Yongjun; Dai, Chaoliu; Guo, Rongping; Guo, Wenzhi; Hao, Chunyi; Huang, Tao; Huang, Zhiyong; Li, Deyu; Li, Gang; Li, Tao; Li, Xiangcheng; Liang, Xiao; Liu, Jingfeng; Liu, Fubao; Lu, Shichun; Lu, Zheng; Lv, Weifu; Mao, Yilei; Shao, Guoliang; Shi, Yinghong; Song, Tianqiang; Tan, Guang; Tang, Yunqiang; Tao, Kaishan; Wan, Chidan; Wang, Guangyi; Wang, Lu; Wang, Shunxiang; Wen, Tianfu; Xing, Baocai; Xiang, Bangde; Yan, Sheng; Yang, Dinghua; Yin, Guowen; Yin, Tao; Yin, Zhenyu; Yu, Zhengping; Zhang, Bixiang; Zhang, Jialin; Zhang, Shuijun; Zhang, Ti; Zhang, Yamin; Zhang, Yubao; Zhang, Aibin; Zhao, Haitao; Zhou, Ledu; Zhang, Wu; Zhu, Zhenyu; Qin, Shukui; Shen, Feng; Cai, Xiujun; Teng, Gaojun; Cai, Jianqiang; Chen, Minshan; Li, Qiang; Liu, Lianxin; Wang, Weilin; Liang, Tingbo; Dong, Jiahong; Chen, Xiaoping; Wang, Xuehao; Zheng, Shusen; Fan, Jia 分享 收藏 分享 收藏 CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-Myc expressionYu, Min-Cheng; Ding, Guang-Yu; Ma, Peng; Chen, Yue-Da; Zhu, Xiao-Dong; Cai, Jia-Bin; Shen, Ying-Hao; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan; Kuang, Ming; Huang, Cheng 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
